CRP and COVID-19: The majority of patients are reported to have lymphopenia, while the most available biomarkers of routine clinical tests including C-reactive protein (CRP), neutrophils and lymphocytes ratio (NLR), lactate dehydrogenase and D-dimer were associated with disease severity and could contribute in predicting clinical outcomes in COVID-19 patients [8, 9].